Global Plasma Protein Therapeutics Market Insights and Forecast to 2028

Report ID: 1228669 | Published Date: Jan 2025 | No. of Page: 113 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Plasma Protein Therapeutics Product Introduction
    1.2 Market by Type
        1.2.1 Global Plasma Protein Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Coagulation Factor
        1.2.3 Immune Globulin
        1.2.4 Albumin
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Plasma Protein Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hemophilia
        1.3.3 PID
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Plasma Protein Therapeutics Sales Estimates and Forecasts 2017-2028
    2.2 Global Plasma Protein Therapeutics Revenue Estimates and Forecasts 2017-2028
    2.3 Global Plasma Protein Therapeutics Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Plasma Protein Therapeutics Sales by Region
        2.4.1 Global Plasma Protein Therapeutics Sales by Region (2017-2022)
        2.4.2 Global Sales Plasma Protein Therapeutics by Region (2023-2028)
    2.5 Global Plasma Protein Therapeutics Revenue by Region
        2.5.1 Global Plasma Protein Therapeutics Revenue by Region (2017-2022)
        2.5.2 Global Plasma Protein Therapeutics Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Plasma Protein Therapeutics Sales by Manufacturers
        3.1.1 Global Top Plasma Protein Therapeutics Manufacturers by Sales (2017-2022)
        3.1.2 Global Plasma Protein Therapeutics Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Plasma Protein Therapeutics in 2021
    3.2 Global Plasma Protein Therapeutics Revenue by Manufacturers
        3.2.1 Global Plasma Protein Therapeutics Revenue by Manufacturers (2017-2022)
        3.2.2 Global Plasma Protein Therapeutics Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Plasma Protein Therapeutics Revenue in 2021
    3.3 Global Plasma Protein Therapeutics Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Plasma Protein Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Plasma Protein Therapeutics Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Plasma Protein Therapeutics Sales by Type
        4.1.1 Global Plasma Protein Therapeutics Historical Sales by Type (2017-2022)
        4.1.2 Global Plasma Protein Therapeutics Forecasted Sales by Type (2023-2028)
        4.1.3 Global Plasma Protein Therapeutics Sales Market Share by Type (2017-2028)
    4.2 Global Plasma Protein Therapeutics Revenue by Type
        4.2.1 Global Plasma Protein Therapeutics Historical Revenue by Type (2017-2022)
        4.2.2 Global Plasma Protein Therapeutics Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Plasma Protein Therapeutics Revenue Market Share by Type (2017-2028)
    4.3 Global Plasma Protein Therapeutics Price by Type
        4.3.1 Global Plasma Protein Therapeutics Price by Type (2017-2022)
        4.3.2 Global Plasma Protein Therapeutics Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Plasma Protein Therapeutics Sales by Application
        5.1.1 Global Plasma Protein Therapeutics Historical Sales by Application (2017-2022)
        5.1.2 Global Plasma Protein Therapeutics Forecasted Sales by Application (2023-2028)
        5.1.3 Global Plasma Protein Therapeutics Sales Market Share by Application (2017-2028)
    5.2 Global Plasma Protein Therapeutics Revenue by Application
        5.2.1 Global Plasma Protein Therapeutics Historical Revenue by Application (2017-2022)
        5.2.2 Global Plasma Protein Therapeutics Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Plasma Protein Therapeutics Revenue Market Share by Application (2017-2028)
    5.3 Global Plasma Protein Therapeutics Price by Application
        5.3.1 Global Plasma Protein Therapeutics Price by Application (2017-2022)
        5.3.2 Global Plasma Protein Therapeutics Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Plasma Protein Therapeutics Market Size by Type
        6.1.1 North America Plasma Protein Therapeutics Sales by Type (2017-2028)
        6.1.2 North America Plasma Protein Therapeutics Revenue by Type (2017-2028)
    6.2 North America Plasma Protein Therapeutics Market Size by Application
        6.2.1 North America Plasma Protein Therapeutics Sales by Application (2017-2028)
        6.2.2 North America Plasma Protein Therapeutics Revenue by Application (2017-2028)
    6.3 North America Plasma Protein Therapeutics Market Size by Country
        6.3.1 North America Plasma Protein Therapeutics Sales by Country (2017-2028)
        6.3.2 North America Plasma Protein Therapeutics Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Plasma Protein Therapeutics Market Size by Type
        7.1.1 Europe Plasma Protein Therapeutics Sales by Type (2017-2028)
        7.1.2 Europe Plasma Protein Therapeutics Revenue by Type (2017-2028)
    7.2 Europe Plasma Protein Therapeutics Market Size by Application
        7.2.1 Europe Plasma Protein Therapeutics Sales by Application (2017-2028)
        7.2.2 Europe Plasma Protein Therapeutics Revenue by Application (2017-2028)
    7.3 Europe Plasma Protein Therapeutics Market Size by Country
        7.3.1 Europe Plasma Protein Therapeutics Sales by Country (2017-2028)
        7.3.2 Europe Plasma Protein Therapeutics Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Plasma Protein Therapeutics Market Size by Type
        8.1.1 Asia Pacific Plasma Protein Therapeutics Sales by Type (2017-2028)
        8.1.2 Asia Pacific Plasma Protein Therapeutics Revenue by Type (2017-2028)
    8.2 Asia Pacific Plasma Protein Therapeutics Market Size by Application
        8.2.1 Asia Pacific Plasma Protein Therapeutics Sales by Application (2017-2028)
        8.2.2 Asia Pacific Plasma Protein Therapeutics Revenue by Application (2017-2028)
    8.3 Asia Pacific Plasma Protein Therapeutics Market Size by Region
        8.3.1 Asia Pacific Plasma Protein Therapeutics Sales by Region (2017-2028)
        8.3.2 Asia Pacific Plasma Protein Therapeutics Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Plasma Protein Therapeutics Market Size by Type
        9.1.1 Latin America Plasma Protein Therapeutics Sales by Type (2017-2028)
        9.1.2 Latin America Plasma Protein Therapeutics Revenue by Type (2017-2028)
    9.2 Latin America Plasma Protein Therapeutics Market Size by Application
        9.2.1 Latin America Plasma Protein Therapeutics Sales by Application (2017-2028)
        9.2.2 Latin America Plasma Protein Therapeutics Revenue by Application (2017-2028)
    9.3 Latin America Plasma Protein Therapeutics Market Size by Country
        9.3.1 Latin America Plasma Protein Therapeutics Sales by Country (2017-2028)
        9.3.2 Latin America Plasma Protein Therapeutics Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Plasma Protein Therapeutics Market Size by Type
        10.1.1 Middle East and Africa Plasma Protein Therapeutics Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Plasma Protein Therapeutics Revenue by Type (2017-2028)
    10.2 Middle East and Africa Plasma Protein Therapeutics Market Size by Application
        10.2.1 Middle East and Africa Plasma Protein Therapeutics Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Plasma Protein Therapeutics Revenue by Application (2017-2028)
    10.3 Middle East and Africa Plasma Protein Therapeutics Market Size by Country
        10.3.1 Middle East and Africa Plasma Protein Therapeutics Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Plasma Protein Therapeutics Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Shire (Baxalta)
        11.1.1 Shire (Baxalta) Corporation Information
        11.1.2 Shire (Baxalta) Overview
        11.1.3 Shire (Baxalta) Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Shire (Baxalta) Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Shire (Baxalta) Recent Developments
    11.2 CSL
        11.2.1 CSL Corporation Information
        11.2.2 CSL Overview
        11.2.3 CSL Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 CSL Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 CSL Recent Developments
    11.3 Grifols
        11.3.1 Grifols Corporation Information
        11.3.2 Grifols Overview
        11.3.3 Grifols Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Grifols Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Grifols Recent Developments
    11.4 Octapharma
        11.4.1 Octapharma Corporation Information
        11.4.2 Octapharma Overview
        11.4.3 Octapharma Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Octapharma Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Octapharma Recent Developments
    11.5 Kedrion
        11.5.1 Kedrion Corporation Information
        11.5.2 Kedrion Overview
        11.5.3 Kedrion Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Kedrion Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Kedrion Recent Developments
    11.6 LFB Group
        11.6.1 LFB Group Corporation Information
        11.6.2 LFB Group Overview
        11.6.3 LFB Group Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 LFB Group Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 LFB Group Recent Developments
    11.7 Biotest
        11.7.1 Biotest Corporation Information
        11.7.2 Biotest Overview
        11.7.3 Biotest Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Biotest Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Biotest Recent Developments
    11.8 BPL
        11.8.1 BPL Corporation Information
        11.8.2 BPL Overview
        11.8.3 BPL Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 BPL Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 BPL Recent Developments
    11.9 RAAS
        11.9.1 RAAS Corporation Information
        11.9.2 RAAS Overview
        11.9.3 RAAS Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 RAAS Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 RAAS Recent Developments
    11.10 CBPO
        11.10.1 CBPO Corporation Information
        11.10.2 CBPO Overview
        11.10.3 CBPO Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 CBPO Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 CBPO Recent Developments
    11.11 Hualan Bio
        11.11.1 Hualan Bio Corporation Information
        11.11.2 Hualan Bio Overview
        11.11.3 Hualan Bio Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Hualan Bio Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Hualan Bio Recent Developments
    11.12 Kamada
        11.12.1 Kamada Corporation Information
        11.12.2 Kamada Overview
        11.12.3 Kamada Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Kamada Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Kamada Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Plasma Protein Therapeutics Industry Chain Analysis
    12.2 Plasma Protein Therapeutics Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Plasma Protein Therapeutics Production Mode & Process
    12.4 Plasma Protein Therapeutics Sales and Marketing
        12.4.1 Plasma Protein Therapeutics Sales Channels
        12.4.2 Plasma Protein Therapeutics Distributors
    12.5 Plasma Protein Therapeutics Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Plasma Protein Therapeutics Industry Trends
    13.2 Plasma Protein Therapeutics Market Drivers
    13.3 Plasma Protein Therapeutics Market Challenges
    13.4 Plasma Protein Therapeutics Market Restraints
14 Key Findings in The Global Plasma Protein Therapeutics Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Plasma Protein Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Coagulation Factor
    Table 3. Major Manufacturers of Immune Globulin
    Table 4. Major Manufacturers of Albumin
    Table 5. Major Manufacturers of Others
    Table 6. Global Plasma Protein Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Plasma Protein Therapeutics Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Plasma Protein Therapeutics Sales by Region (2017-2022) & (K Units)
    Table 9. Global Plasma Protein Therapeutics Sales Market Share by Region (2017-2022)
    Table 10. Global Plasma Protein Therapeutics Sales by Region (2023-2028) & (K Units)
    Table 11. Global Plasma Protein Therapeutics Sales Market Share by Region (2023-2028)
    Table 12. Global Plasma Protein Therapeutics Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Plasma Protein Therapeutics Revenue Market Share by Region (2017-2022)
    Table 14. Global Plasma Protein Therapeutics Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Plasma Protein Therapeutics Revenue Market Share by Region (2023-2028)
    Table 16. Global Plasma Protein Therapeutics Sales by Manufacturers (2017-2022) & (K Units)
    Table 17. Global Plasma Protein Therapeutics Sales Share by Manufacturers (2017-2022)
    Table 18. Global Plasma Protein Therapeutics Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Plasma Protein Therapeutics Revenue Share by Manufacturers (2017-2022)
    Table 20. Plasma Protein Therapeutics Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 21. Global Plasma Protein Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Plasma Protein Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Protein Therapeutics as of 2021)
    Table 23. Plasma Protein Therapeutics Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Plasma Protein Therapeutics Product Offered
    Table 25. Date of Manufacturers Enter into Plasma Protein Therapeutics Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Plasma Protein Therapeutics Sales by Type (2017-2022) & (K Units)
    Table 28. Global Plasma Protein Therapeutics Sales by Type (2023-2028) & (K Units)
    Table 29. Global Plasma Protein Therapeutics Sales Share by Type (2017-2022)
    Table 30. Global Plasma Protein Therapeutics Sales Share by Type (2023-2028)
    Table 31. Global Plasma Protein Therapeutics Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Plasma Protein Therapeutics Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Plasma Protein Therapeutics Revenue Share by Type (2017-2022)
    Table 34. Global Plasma Protein Therapeutics Revenue Share by Type (2023-2028)
    Table 35. Plasma Protein Therapeutics Price by Type (2017-2022) & (USD/Unit)
    Table 36. Global Plasma Protein Therapeutics Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 37. Global Plasma Protein Therapeutics Sales by Application (2017-2022) & (K Units)
    Table 38. Global Plasma Protein Therapeutics Sales by Application (2023-2028) & (K Units)
    Table 39. Global Plasma Protein Therapeutics Sales Share by Application (2017-2022)
    Table 40. Global Plasma Protein Therapeutics Sales Share by Application (2023-2028)
    Table 41. Global Plasma Protein Therapeutics Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Plasma Protein Therapeutics Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Plasma Protein Therapeutics Revenue Share by Application (2017-2022)
    Table 44. Global Plasma Protein Therapeutics Revenue Share by Application (2023-2028)
    Table 45. Plasma Protein Therapeutics Price by Application (2017-2022) & (USD/Unit)
    Table 46. Global Plasma Protein Therapeutics Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 47. North America Plasma Protein Therapeutics Sales by Type (2017-2022) & (K Units)
    Table 48. North America Plasma Protein Therapeutics Sales by Type (2023-2028) & (K Units)
    Table 49. North America Plasma Protein Therapeutics Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Plasma Protein Therapeutics Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Plasma Protein Therapeutics Sales by Application (2017-2022) & (K Units)
    Table 52. North America Plasma Protein Therapeutics Sales by Application (2023-2028) & (K Units)
    Table 53. North America Plasma Protein Therapeutics Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Plasma Protein Therapeutics Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Plasma Protein Therapeutics Sales by Country (2017-2022) & (K Units)
    Table 56. North America Plasma Protein Therapeutics Sales by Country (2023-2028) & (K Units)
    Table 57. North America Plasma Protein Therapeutics Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Plasma Protein Therapeutics Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Plasma Protein Therapeutics Sales by Type (2017-2022) & (K Units)
    Table 60. Europe Plasma Protein Therapeutics Sales by Type (2023-2028) & (K Units)
    Table 61. Europe Plasma Protein Therapeutics Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Plasma Protein Therapeutics Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Plasma Protein Therapeutics Sales by Application (2017-2022) & (K Units)
    Table 64. Europe Plasma Protein Therapeutics Sales by Application (2023-2028) & (K Units)
    Table 65. Europe Plasma Protein Therapeutics Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Plasma Protein Therapeutics Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Plasma Protein Therapeutics Sales by Country (2017-2022) & (K Units)
    Table 68. Europe Plasma Protein Therapeutics Sales by Country (2023-2028) & (K Units)
    Table 69. Europe Plasma Protein Therapeutics Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Plasma Protein Therapeutics Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Plasma Protein Therapeutics Sales by Type (2017-2022) & (K Units)
    Table 72. Asia Pacific Plasma Protein Therapeutics Sales by Type (2023-2028) & (K Units)
    Table 73. Asia Pacific Plasma Protein Therapeutics Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Plasma Protein Therapeutics Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Plasma Protein Therapeutics Sales by Application (2017-2022) & (K Units)
    Table 76. Asia Pacific Plasma Protein Therapeutics Sales by Application (2023-2028) & (K Units)
    Table 77. Asia Pacific Plasma Protein Therapeutics Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Plasma Protein Therapeutics Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Plasma Protein Therapeutics Sales by Region (2017-2022) & (K Units)
    Table 80. Asia Pacific Plasma Protein Therapeutics Sales by Region (2023-2028) & (K Units)
    Table 81. Asia Pacific Plasma Protein Therapeutics Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Plasma Protein Therapeutics Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Plasma Protein Therapeutics Sales by Type (2017-2022) & (K Units)
    Table 84. Latin America Plasma Protein Therapeutics Sales by Type (2023-2028) & (K Units)
    Table 85. Latin America Plasma Protein Therapeutics Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Plasma Protein Therapeutics Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Plasma Protein Therapeutics Sales by Application (2017-2022) & (K Units)
    Table 88. Latin America Plasma Protein Therapeutics Sales by Application (2023-2028) & (K Units)
    Table 89. Latin America Plasma Protein Therapeutics Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Plasma Protein Therapeutics Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Plasma Protein Therapeutics Sales by Country (2017-2022) & (K Units)
    Table 92. Latin America Plasma Protein Therapeutics Sales by Country (2023-2028) & (K Units)
    Table 93. Latin America Plasma Protein Therapeutics Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Plasma Protein Therapeutics Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Plasma Protein Therapeutics Sales by Type (2017-2022) & (K Units)
    Table 96. Middle East and Africa Plasma Protein Therapeutics Sales by Type (2023-2028) & (K Units)
    Table 97. Middle East and Africa Plasma Protein Therapeutics Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Plasma Protein Therapeutics Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Plasma Protein Therapeutics Sales by Application (2017-2022) & (K Units)
    Table 100. Middle East and Africa Plasma Protein Therapeutics Sales by Application (2023-2028) & (K Units)
    Table 101. Middle East and Africa Plasma Protein Therapeutics Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Plasma Protein Therapeutics Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Plasma Protein Therapeutics Sales by Country (2017-2022) & (K Units)
    Table 104. Middle East and Africa Plasma Protein Therapeutics Sales by Country (2023-2028) & (K Units)
    Table 105. Middle East and Africa Plasma Protein Therapeutics Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Plasma Protein Therapeutics Revenue by Country (2023-2028) & (US$ Million)
    Table 107. Shire (Baxalta) Corporation Information
    Table 108. Shire (Baxalta) Description and Major Businesses
    Table 109. Shire (Baxalta) Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 110. Shire (Baxalta) Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Shire (Baxalta) Recent Developments
    Table 112. CSL Corporation Information
    Table 113. CSL Description and Major Businesses
    Table 114. CSL Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 115. CSL Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. CSL Recent Developments
    Table 117. Grifols Corporation Information
    Table 118. Grifols Description and Major Businesses
    Table 119. Grifols Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 120. Grifols Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Grifols Recent Developments
    Table 122. Octapharma Corporation Information
    Table 123. Octapharma Description and Major Businesses
    Table 124. Octapharma Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 125. Octapharma Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Octapharma Recent Developments
    Table 127. Kedrion Corporation Information
    Table 128. Kedrion Description and Major Businesses
    Table 129. Kedrion Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 130. Kedrion Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Kedrion Recent Developments
    Table 132. LFB Group Corporation Information
    Table 133. LFB Group Description and Major Businesses
    Table 134. LFB Group Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 135. LFB Group Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. LFB Group Recent Developments
    Table 137. Biotest Corporation Information
    Table 138. Biotest Description and Major Businesses
    Table 139. Biotest Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 140. Biotest Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Biotest Recent Developments
    Table 142. BPL Corporation Information
    Table 143. BPL Description and Major Businesses
    Table 144. BPL Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 145. BPL Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. BPL Recent Developments
    Table 147. RAAS Corporation Information
    Table 148. RAAS Description and Major Businesses
    Table 149. RAAS Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 150. RAAS Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. RAAS Recent Developments
    Table 152. CBPO Corporation Information
    Table 153. CBPO Description and Major Businesses
    Table 154. CBPO Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 155. CBPO Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. CBPO Recent Developments
    Table 157. Hualan Bio Corporation Information
    Table 158. Hualan Bio Description and Major Businesses
    Table 159. Hualan Bio Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 160. Hualan Bio Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 161. Hualan Bio Recent Developments
    Table 162. Kamada Corporation Information
    Table 163. Kamada Description and Major Businesses
    Table 164. Kamada Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 165. Kamada Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 166. Kamada Recent Developments
    Table 167. Key Raw Materials Lists
    Table 168. Raw Materials Key Suppliers Lists
    Table 169. Plasma Protein Therapeutics Distributors List
    Table 170. Plasma Protein Therapeutics Customers List
    Table 171. Plasma Protein Therapeutics Market Trends
    Table 172. Plasma Protein Therapeutics Market Drivers
    Table 173. Plasma Protein Therapeutics Market Challenges
    Table 174. Plasma Protein Therapeutics Market Restraints
    Table 175. Research Programs/Design for This Report
    Table 176. Key Data Information from Secondary Sources
    Table 177. Key Data Information from Primary Sources
List of Figures
    Figure 1. Plasma Protein Therapeutics Product Picture
    Figure 3. Global Plasma Protein Therapeutics Market Share by Type in 2021 & 2028
    Figure 3. Coagulation Factor Product Picture
    Figure 4. Immune Globulin Product Picture
    Figure 5. Albumin Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Plasma Protein Therapeutics Market Share by Application in 2021 & 2028
    Figure 8. Hemophilia
    Figure 9. PID
    Figure 10. Others
    Figure 11. Plasma Protein Therapeutics Report Years Considered
    Figure 12. Global Plasma Protein Therapeutics Sales 2017-2028 (K Units)
    Figure 13. Global Plasma Protein Therapeutics Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Plasma Protein Therapeutics Revenue 2017-2028 (US$ Million)
    Figure 15. Global Plasma Protein Therapeutics Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 16. Global Plasma Protein Therapeutics Sales Market Share by Region (2017-2022)
    Figure 17. Global Plasma Protein Therapeutics Sales Market Share by Region (2023-2028)
    Figure 18. North America Plasma Protein Therapeutics Sales YoY (2017-2028) & (K Units)
    Figure 19. North America Plasma Protein Therapeutics Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Europe Plasma Protein Therapeutics Sales YoY (2017-2028) & (K Units)
    Figure 21. Europe Plasma Protein Therapeutics Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Asia-Pacific Plasma Protein Therapeutics Sales YoY (2017-2028) & (K Units)
    Figure 23. Asia-Pacific Plasma Protein Therapeutics Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Latin America Plasma Protein Therapeutics Sales YoY (2017-2028) & (K Units)
    Figure 25. Latin America Plasma Protein Therapeutics Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Middle East & Africa Plasma Protein Therapeutics Sales YoY (2017-2028) & (K Units)
    Figure 27. Middle East & Africa Plasma Protein Therapeutics Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. The Plasma Protein Therapeutics Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 29. The Top 5 and 10 Largest Manufacturers of Plasma Protein Therapeutics in the World: Market Share by Plasma Protein Therapeutics Revenue in 2021
    Figure 30. Global Plasma Protein Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 31. Global Plasma Protein Therapeutics Sales Market Share by Type (2017-2028)
    Figure 32. Global Plasma Protein Therapeutics Revenue Market Share by Type (2017-2028)
    Figure 33. Global Plasma Protein Therapeutics Sales Market Share by Application (2017-2028)
    Figure 34. Global Plasma Protein Therapeutics Revenue Market Share by Application (2017-2028)
    Figure 35. North America Plasma Protein Therapeutics Sales Market Share by Type (2017-2028)
    Figure 36. North America Plasma Protein Therapeutics Revenue Market Share by Type (2017-2028)
    Figure 37. North America Plasma Protein Therapeutics Sales Market Share by Application (2017-2028)
    Figure 38. North America Plasma Protein Therapeutics Revenue Market Share by Application (2017-2028)
    Figure 39. North America Plasma Protein Therapeutics Sales Share by Country (2017-2028)
    Figure 40. North America Plasma Protein Therapeutics Revenue Share by Country (2017-2028)
    Figure 41. U.S. Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 42. Canada Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 43. Europe Plasma Protein Therapeutics Sales Market Share by Type (2017-2028)
    Figure 44. Europe Plasma Protein Therapeutics Revenue Market Share by Type (2017-2028)
    Figure 45. Europe Plasma Protein Therapeutics Sales Market Share by Application (2017-2028)
    Figure 46. Europe Plasma Protein Therapeutics Revenue Market Share by Application (2017-2028)
    Figure 47. Europe Plasma Protein Therapeutics Sales Share by Country (2017-2028)
    Figure 48. Europe Plasma Protein Therapeutics Revenue Share by Country (2017-2028)
    Figure 49. Germany Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 50. France Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 51. U.K. Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 52. Italy Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 53. Russia Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 54. Asia Pacific Plasma Protein Therapeutics Sales Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Plasma Protein Therapeutics Revenue Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Plasma Protein Therapeutics Sales Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Plasma Protein Therapeutics Revenue Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Plasma Protein Therapeutics Sales Share by Region (2017-2028)
    Figure 59. Asia Pacific Plasma Protein Therapeutics Revenue Share by Region (2017-2028)
    Figure 60. China Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 61. Japan Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 62. South Korea Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 63. India Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 64. Australia Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 65. Taiwan Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 66. Indonesia Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 67. Thailand Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 68. Malaysia Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 69. Philippines Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 70. Latin America Plasma Protein Therapeutics Sales Market Share by Type (2017-2028)
    Figure 71. Latin America Plasma Protein Therapeutics Revenue Market Share by Type (2017-2028)
    Figure 72. Latin America Plasma Protein Therapeutics Sales Market Share by Application (2017-2028)
    Figure 73. Latin America Plasma Protein Therapeutics Revenue Market Share by Application (2017-2028)
    Figure 74. Latin America Plasma Protein Therapeutics Sales Share by Country (2017-2028)
    Figure 75. Latin America Plasma Protein Therapeutics Revenue Share by Country (2017-2028)
    Figure 76. Mexico Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 77. Brazil Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 78. Argentina Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 79. Middle East and Africa Plasma Protein Therapeutics Sales Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Plasma Protein Therapeutics Revenue Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Plasma Protein Therapeutics Sales Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Plasma Protein Therapeutics Revenue Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Plasma Protein Therapeutics Sales Share by Country (2017-2028)
    Figure 84. Middle East and Africa Plasma Protein Therapeutics Revenue Share by Country (2017-2028)
    Figure 85. Turkey Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 86. Saudi Arabia Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 87. U.A.E Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 88. Plasma Protein Therapeutics Value Chain
    Figure 89. Plasma Protein Therapeutics Production Process
    Figure 90. Channels of Distribution
    Figure 91. Distributors Profiles
    Figure 92. Bottom-up and Top-down Approaches for This Report
    Figure 93. Data Triangulation
    Figure 94. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Shire (Baxalta)
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Kamada
Frequently Asked Questions
Plasma Protein Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Plasma Protein Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Plasma Protein Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Rubber Conveyor Belt

Rubber Conveyor Belt market is segmented by Type and by Application. Players, stakeholders, and o ... Read More

Trekking Poles

Trekking Poles market is segmented by Type and by Application. Players, stakeholders, and other p ... Read More

Tubular GEL Battery

Tubular GEL Battery market is segmented by Type and by Application. Players, stakeholders, and ot ... Read More